Melatonin for ulcerative colitis? [16]

American Journal of Gastroenterology

Volumn 98, Issue 1, 2003, Pages 232-233

  Mann, Steven ^a,b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b OLDCHURCH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; MESALAZINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG SELF ADMINISTRATION; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SUPPOSITORY; ULCERATIVE COLITIS; UNITED STATES;

EID: 0037254010     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07190.x     Document Type: Letter

References (5)

1. Bonn D. Melatonin's multifarious marvels: Miracle or myth? Lancet 1996;347:184.
2. Messner M, Huether G, Lorf T, et al. Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci 2001;69:543-51.
3. Motilva V, Cabeza J, Alarcon de la Lastra C. New issues about melatonin and its effects on the digestive system. Curr Pharmaceut Des 2001;7:909-31.
4. Cuzzocrea S, Mazzon E, Serraino I, et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001;30:1-12.
5. Pharmaceuticals: Restrictions in use and availability. Update of the sixth issue, April 1999. Essential drugs and medicines - Quality assurance and safety of medicines, World Health Organization.